Bottom line
IHE vs PRHSX: the short answer
IHE (iShares U.S. Pharmaceuticals ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 40% by weight.
But PRHSX is far broader, holding 279 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
IHE is cheaper at 0.37% vs 0.83% — a difference of $46 a year per $10,000 invested.
Over five years, IHE returned +9.1% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
IHE vs PRHSX side by side
| IHE | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.83% |
| Annual cost per $10k | $37 | $83 |
| 10-yr cost on $10k (prospectus) | $468 | $1,025 |
| Max front load | None | — |
| 12b-1 fee | 0% | — |
| 1-yr return | +31.7% | +17.7% |
| 5-yr return (annualized) | +9.1% | +4.2% |
| 10-yr return (annualized) | +6.2% | +9.1% |
| Best quarter | +17.6% | +23.5% |
| Worst quarter | −16.0% | −15.8% |
| Net assets (fund) | $1.1B | $11.9B |
| Number of holdings | 59 | 279 |
| Portfolio turnover | 29% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHE | PRHSX | Difference |
|---|---|---|---|
| 2025 | +31.7% | +17.7% | +14.0% |
| 2024 | +8.1% | +1.8% | +6.3% |
| 2023 | +1.0% | +3.1% | −2.1% |
| 2022 | −4.8% | −12.2% | +7.4% |
| 2021 | +12.8% | +13.3% | −0.4% |
| 2020 | +13.8% | +30.1% | −16.3% |
| 2019 | +15.5% | +29.1% | −13.6% |
| 2018 | −7.7% | +1.2% | −8.9% |
| 2017 | +10.7% | +28.0% | −17.3% |
| 2016 | −11.7% | −10.4% | −1.4% |
Source: Fund prospectus bar charts
Holdings overlap
4 of IHE's top 25 holdings also appear in PRHSX's top 25.
| Holding | IHE | PRHSX |
|---|---|---|
| Johnson & Johnson | 22.44% | 6.63% |
| Eli Lilly And Company | 22.25% | 14.28% |
| Merck & Co., Inc. | 4.55% | 4.01% |
| Bristol-myers Squibb Company | 4.37% | 2.11% |
Source: SEC Form N-PORT
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between IHE and PRHSX?
Which is cheaper, IHE or PRHSX?
Should I own both IHE and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.